看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Ps Multiple | 0.4x - 0.4x | 0.4x |
Selected Fwd Ps Multiple | 0.2x - 0.3x | 0.2x |
Fair Value | $0.075 - $0.083 | $0.079 |
Upside | 50.1% - 65.9% | 58.0% |
Benchmarks | Ticker | Full Ticker |
---|---|---|
4Front Ventures Corp. | - | CNSX:FFNT |
Harmony Biosciences Holdings, Inc. | - | NasdaqGM:HRMY |
Evolus, Inc. | - | NasdaqGM:EOLS |
Tarsus Pharmaceuticals, Inc. | - | NasdaqGS:TARS |
Bio Essence Corporation | - | OTCPK:BIOE |
FLUENT Corp. | - | CNSX:FNT.U |
Select Price / LTM Sales Ratio | ||||||||
Benchmark Companies | ||||||||
FFNT | HRMY | EOLS | TARS | BIOE | FNT.U | |||
CNSX:FFNT | NasdaqGM:HRMY | NasdaqGM:EOLS | NasdaqGS:TARS | OTCPK:BIOE | CNSX:FNT.U | |||
Historical Sales Growth | ||||||||
5Y CAGR | 91.7% | 160.2% | 50.1% | NM- | -17.1% | 29.4% | ||
3Y CAGR | 19.1% | 32.8% | 38.8% | 47.5% | -28.5% | 16.5% | ||
Latest Twelve Months | -27.5% | 20.6% | 25.4% | 449.0% | NM | 6.4% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | -170.4% | 5.6% | -83.6% | -262.7% | -170.1% | -54.2% | ||
Prior Fiscal Year | -19.8% | 22.1% | -30.5% | -778.9% | NA | -23.4% | ||
Latest Fiscal Year | -45.9% | 20.4% | -18.9% | -63.2% | -483.3% | -39.0% | ||
Latest Twelve Months | -46.6% | 20.5% | -18.9% | -44.9% | -483.3% | -39.0% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | -13.2x | 7.0x | -25.3x | -15.3x | -23.0x | 5.7x | ||
Price / LTM Sales | 0.0x | 2.6x | 2.3x | 8.5x | 24.2x | 0.2x | ||
LTM P/E Ratio | -0.1x | 12.8x | -11.4x | -18.9x | -5.0x | -0.6x | ||
Low | Mid | High | ||||||
Benchmark LTM P/S Ratio | 0.0x | 2.6x | 24.2x | |||||
Historical LTM P/S Ratio | 0.2x | 0.4x | 3.3x | |||||
Selected Price / Sales Multiple | 0.4x | 0.4x | 0.4x | |||||
(x) LTM Sales | 104 | 104 | 104 | |||||
(=) Equity Value | 39 | 41 | 43 | |||||
(/) Shares Outstanding | 472.3 | 472.3 | 472.3 | |||||
Implied Value Range | 0.08 | 0.09 | 0.09 | |||||
FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 0.08 | 0.09 | 0.09 | 0.05 | ||||
Upside / (Downside) | 66.2% | 75.0% | 83.7% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | FFNT | HRMY | EOLS | TARS | BIOE | FNT.U | |
Value of Common Equity | 3 | 1,958 | 642 | 1,981 | 8 | 24 | |
(/) Shares Outstanding | 916.4 | 57.4 | 63.6 | 42.0 | 38.0 | 472.3 | |
Implied Stock Price | 0.00 | 34.09 | 10.09 | 47.14 | 0.21 | 0.05 | |
FX Conversion Rate to Trading Currency | 0.72 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 0.01 | 34.09 | 10.09 | 47.14 | 0.21 | 0.05 | |
Trading Currency | CAD | USD | USD | USD | USD | USD | |
FX Rate to Reporting Currency | 0.72 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |